February 23, 2017 10:56 AM EST
News Briefing

J&J leads a $25M A round for can­cer start­up; BMJ frets about Trump’s im­pact on the sci­en­tif­ic com­mu­ni­ty

Shehla Shakoor

Managing Director

• J&J In­no­va­tion has led a $25 mil­lion start­up round for Fu­sion Phar­ma­ceu­ti­cals. The Cana­di­an biotech is work­ing on tar­get­ed al­pha-par­ti­cle emit­ting ra­dio­ther­a­peu­tics which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sen­ate Ju­di­cia­ry Com­mit­tee ad­vances patent bill with new pro­tec­tions for phar­ma chal­lenges

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

A service from the Financial Times